LG Electronics Inc (066570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
LG Electronics Inc (LG Electronics) manufactures and distributes consumer electronics and home appliances. The company’s product portfolio comprises televisions, monitors, laptops, refrigerators, audio and beauty appliances, video equipment, washing machines, air conditioners, dishwashers, water purifiers, and vacuum cleaners. It also offers vehicle components, information displays, substrate and material, motor and sensor components, optic solutions, automotive components, and camera modules. The company offers its products under the LG InstaView, UVnano, AI Direct Drive, and CordZero brands. It has business presence across Europe, the Americas, the Middle East, Africa, and Asia-Pacific. LG Electronics is headquartered in Seoul, South Korea.
LG Electronics Inc Key Recent Developments
Jun 15, 2026: Jackery and Homey Partner to Advance Plug-in Home Battery Integration in Europe
May 20, 2026: LG Aligns With UAE Energy Conservation Goals, Championing Efficient Cooling Solutions
Apr 28, 2026: LG HVAC Engineers Prioritize Safety and Innovation in Harsh Middle East Conditions
Jan 27, 2026: LG Advances Energy-Efficient District Cooling in the GCC with Chillers
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Celltrion Inc - Key Facts
Celltrion Inc - Key Employees
Celltrion Inc - Key Employee Biographies
Celltrion Inc - Major Products and Services
Celltrion Inc - History
Celltrion Inc - Company Statement
Celltrion Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Celltrion Inc - Business Description
Business Segment: Biopharmaceutical Medicines
Overview
Performance
Business Segment: Chemical Medicines
Overview
Performance
Business Segment: Other
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Central and South America
Performance
Geographical Segment: Domestic Market
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
R&D Overview
Celltrion Inc - Corporate Strategy
Celltrion Inc - SWOT Analysis
SWOT Analysis - Overview
Celltrion Inc - Strengths
Celltrion Inc - Weaknesses
Celltrion Inc - Opportunities
Celltrion Inc - Threats
Celltrion Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Celltrion Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
Jun 15, 2026: Celltrion Launches Two New Anticancer Drugs in Vietnam Accelerating Targeting of Global Pharma Emerging Markets in Asia and Latin America
May 27, 2026: Celltrion Science & Innovation Day 2026' Held Analysts and Institutional Investors Focus on 'New Drug Valuations
May 26, 2026: Celltrion Introduces AI to Three Major Areas: New Drug Development, Manufacturing, and Administration; Establishes Differentiated Systems for Each Task to Expand Global Competitiveness
May 13, 2026: Celltrion Included in Dow Jones Sustainability World Index for Two Consecutive Years Proving Responsible Management Through 'Global Standard' ESG Evaluation
May 06, 2026: Celltrion Records 1.145 Trillion Won in Revenue and 321.9 Billion Won in Operating Profit in the First Quarter
Apr 23, 2026: Celltrion Enters Patient Dosage for All 3 New ADC Drugs Clinical Trials on Track, Accelerating Leap to Global New Drug Company
Apr 16, 2026: Celltrion Sees Widespread Prescriptions for Key Product Lines in Europe Expectations for Success of High-Profit New Products Growing Driven by Field-Oriented Direct Sales Performance
Apr 15, 2026: Celltrion Selected Only in Korea for Top 1% in Biotechnology Sector of S&P ESG Evaluation Recognized for Practicing Top-Tier Global ESG Management
Mar 24, 2026: Celltrion Announces KRW 1.2Tn Expansion of New DS Production Facilities in Songdo; Adds 180,000L of DS capacity, bringing total capacity to 570,000L
Mar 18, 2026: Celltrion Healthcare Japan and CMIC Group Sign MOU to Expand Biosimilars in Japan
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
Celltrion Inc, Key Facts
Celltrion Inc, Key Employees
Celltrion Inc, Key Employee Biographies
Celltrion Inc, Major Products and Services
Celltrion Inc, History
Celltrion Inc, Other Locations
Celltrion Inc, Subsidiaries
Celltrion Inc, Key Competitors
Celltrion Inc, Ratios based on current share price
Celltrion Inc, Annual Ratios
Celltrion Inc, Interim Ratios
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Celltrion Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Celltrion Inc, Performance Chart (2021 - 2025)
Celltrion Inc, Ratio Charts
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net